YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Australian Research Institute IDs Novel Syndrome Variants with NextCODE Tools


June 23, 2014 | The ANZAC Research Institute in Sydney, Australia, has used NextCODE Health's Clinical Sequence Analyzer and Sequence Miner tools to ID novel sequence variants behind X-linked Charcot-Marie-Tooth syndrome (CMTX). "NextCODE's platform has enabled us to use whole-genome sequencing to identify variants never before linked to CMTX," said Dr Marina Kennerson, a principle research fellow at ANZAC in a NextCODE press release. The two tools are part of a suite of NextCODE offerings that were born from deCODE's data architecture. NextCODE Press Release
View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.